Details of the Drug

General Information of Drug (ID: DMPIQAF)

Drug Name

KD018

Indication

Disease Entry	ICD 11	Status	REF
Liver cancer	2C12	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00730158) A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer. U.S. National Institutes of Health.